KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Regeneron Pharmaceuticals (REGN) Income from Continuing Operations (2016 - 2025)

Regeneron Pharmaceuticals has reported Income from Continuing Operations over the past 17 years, most recently at 844600000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 844600000.0 for Q4 2025, down 7.97% from a year ago — trailing twelve months through Dec 2025 was 4504900000.0 (up 2.09% YoY), and the annual figure for FY2025 was 4504900000.0, up 2.09%.
  • Income from Continuing Operations for Q4 2025 was 844600000.0 at Regeneron Pharmaceuticals, down from 1460000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for REGN hit a ceiling of 3098900000.0 in Q2 2021 and a floor of 722000000.0 in Q1 2024.
  • Median Income from Continuing Operations over the past 5 years was 1137400000.0 (2021), compared with a mean of 1264240000.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 245.36% in 2021 and later crashed 72.5% in 2022.
  • Regeneron Pharmaceuticals' Income from Continuing Operations stood at 2229000000.0 in 2021, then crashed by 46.29% to 1197100000.0 in 2022, then decreased by 3.13% to 1159600000.0 in 2023, then fell by 20.86% to 917700000.0 in 2024, then decreased by 7.97% to 844600000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 844600000.0 (Q4 2025), 1460000000.0 (Q3 2025), and 1391600000.0 (Q2 2025) per Business Quant data.